Novel approaches to three drug antiretroviral therapy for HIV infection in 1997

Robert Leo Murphy

Novel approaches to three drug antiretroviral therapy for HIV infection in 1997

Robert Leo Murphy^*

^*Corresponding author for this work

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Article › peer-review

Abstract

Study results currently support the simultaneous use of three antiretroviral agents including two nucleoside reverse transcriptase inhibitors and a protease inhibitor for the treatment of human immunodeficiency (HIV) infection. Such regimens have been recommended by the USA panel of the International AIDS Society for all patients considering treatment, and similar recommendations are being proposed by other organisations as well. This paper reviews the currently recommended triple therapy regimens, as well as novel triple therapy regimens using didanosine (2',3'-dideoxyinosine; ddI] plus stavudine (2',3'-didehydro-2',3'- dideoxythymidine; d4T).

Original language	English (US)
Pages (from-to)	143-147
Number of pages	5
Journal	Antiviral Therapy
Volume	2
Issue number	SUPPL.3
State	Published - Dec 1 1997

ASJC Scopus subject areas

Pharmacology

Fingerprint Dive into the research topics of 'Novel approaches to three drug antiretroviral therapy for HIV infection in 1997'. Together they form a unique fingerprint.

Cite this

@article{dcc09ca7087c4d89864e9768e6de5b7b,

title = "Novel approaches to three drug antiretroviral therapy for HIV infection in 1997",

abstract = "Study results currently support the simultaneous use of three antiretroviral agents including two nucleoside reverse transcriptase inhibitors and a protease inhibitor for the treatment of human immunodeficiency (HIV) infection. Such regimens have been recommended by the USA panel of the International AIDS Society for all patients considering treatment, and similar recommendations are being proposed by other organisations as well. This paper reviews the currently recommended triple therapy regimens, as well as novel triple therapy regimens using didanosine (2',3'-dideoxyinosine; ddI] plus stavudine (2',3'-didehydro-2',3'- dideoxythymidine; d4T).",

author = "Murphy, {Robert Leo}",

year = "1997",

month = dec,

day = "1",

language = "English (US)",

volume = "2",

pages = "143--147",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "International Medical Press Ltd",

number = "SUPPL.3",

}

TY - JOUR

T1 - Novel approaches to three drug antiretroviral therapy for HIV infection in 1997

AU - Murphy, Robert Leo

PY - 1997/12/1

Y1 - 1997/12/1

N2 - Study results currently support the simultaneous use of three antiretroviral agents including two nucleoside reverse transcriptase inhibitors and a protease inhibitor for the treatment of human immunodeficiency (HIV) infection. Such regimens have been recommended by the USA panel of the International AIDS Society for all patients considering treatment, and similar recommendations are being proposed by other organisations as well. This paper reviews the currently recommended triple therapy regimens, as well as novel triple therapy regimens using didanosine (2',3'-dideoxyinosine; ddI] plus stavudine (2',3'-didehydro-2',3'- dideoxythymidine; d4T).

AB - Study results currently support the simultaneous use of three antiretroviral agents including two nucleoside reverse transcriptase inhibitors and a protease inhibitor for the treatment of human immunodeficiency (HIV) infection. Such regimens have been recommended by the USA panel of the International AIDS Society for all patients considering treatment, and similar recommendations are being proposed by other organisations as well. This paper reviews the currently recommended triple therapy regimens, as well as novel triple therapy regimens using didanosine (2',3'-dideoxyinosine; ddI] plus stavudine (2',3'-didehydro-2',3'- dideoxythymidine; d4T).

UR - http://www.scopus.com/inward/record.url?scp=0031454296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031454296&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031454296

VL - 2

SP - 143

EP - 147

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - SUPPL.3

ER -